The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Subcutaneous Administration of a Novel Anti-NGF Monoclonal Antibody (AK115) in Healthy Participants: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase I Clinical Trial. - Zhang J; Fan YX; Huang Y; Guan R; Li R; Long S; Yang M; Yu B; Wang GQ; Chen P; Gong X; Li B; et al. (Drug design, development and therapy, 2025)